Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.
To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.
|Study Number||Lead Group||Study Title||CIRB||Study Status|
|ECOG-EA9131||ECOG-ACRIN||A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL)||Cancer Prevention and Control CIRB||Available to Open|
|URCC-18004CD||NCORP-University of Rochester Cancer Center||Understanding the Impact of Drug Shortages on Oncology Care Delivery||Cancer Prevention and Control CIRB||Completed|
|S1820||SWOG||A Randomized Trial of the Altering Intake, Managing Symptoms Intervention for Bowel Dysfunction in Rectal Cancer Survivors Compared to a Healthy Living Education Control: A Feasibility and Preliminary Efficacy Study (AIMS-RC)||Cancer Prevention and Control CIRB||Available to Open|
|DCP-001||NCI||Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP)||Cancer Prevention and Control CIRB||Available to Open|
|EAQ162CD||ECOG-ACRIN||Longitudinal Assessment of Financial Burden in Patients with Colon or Rectal Cancer Treated with Curative Intent||Cancer Prevention and Control CIRB||Available to Open|
|A231602CD||Alliance||Assessing Financial Difficulty in Patients with Blood Cancers||Cancer Prevention and Control CIRB||Available to Open|
|A191402CD||Alliance||Testing Decision Aids to Improve Prostate Cancer Decisions for Minority Men||Cancer Prevention and Control CIRB||Available to Open|
|NRG-CC001||NRG||A Randomized Phase III Trial Of Memantine And Whole-Brain Radiotherapy With Or Without Hippocampal Avoidance In Patients With Brain Metastases||Cancer Prevention and Control CIRB||Completed|
|S1600||SWOG||A Randomized Phase III Double-Blind Clinical Trial Evaluating the Effect of Immune-Enhancing Nutrition on Radical Cystectomy Outcomes||Cancer Prevention and Control CIRB||Available to Open|
|UAZ2016-08-02||CLO-University of Arizona||A feasibility trial of alternating intravaginal application of 5-fluorouracil and imiquimod for treatment of high-grade cervical squamous intraepithelial lesions||Cancer Prevention and Control CIRB||Available to Open|